A. urinae isolates, moxifloxacin (MIC 50 , 0.12 g/ml) was 4-and 16-fold more active than ciprofloxacin/levofloxacin (MIC 50 , 0.5 g/ml) and ofloxacin (MIC 50 , 2 g/ml), respectively (Table 1) . Against A. sanguinicola isolates, moxifloxacin (MIC 50 , 0.25 g/ ml) was also 4-and 16-fold more active than ciprofloxacin/ levofloxacin (MIC 50 , 1 g/ml) and ofloxacin (MIC 50 , 4 g/ml), respectively ( Table 1 ). The potent activity of moxifloxacin against Aerococcus spp. is concordant with data previously reported (8) . Finally, active efflux did not seem to play a major role in fluoroquinolone resistance in aerococci, since the MICs of ciprofloxacin were similar in the absence or presence of reserpin (Table 1) .
Following the use of degenerate primers, the DNA fragments corresponding to QRDRs of GyrA, GyrB, ParC, and ParE were amplified using standard PCR conditions with novel specific primers ( Table 2 ). The sequences of GyrA, GyrB, ParC, and ParE of A. urinae were 100%, 98%, 88%, and 93% identical to those of A. sanguinicola, respectively. In A. urinae, a serine residue and a glutamate residue were found at positions 84 and 88 (corresponding to 83 and 87 in Escherichia coli numbering) in GyrA and also at positions 79 and 83 (corresponding to 80 and 84 in E. coli numbering) in ParC, as described in Enterococcus faecalis (9) . The unique difference with A. sanguinicola was the presence of an aspartate residue at position 83 in ParC, as described in Streptococcus pneumoniae (9) . Whereas all susceptible strains possessed no mutation, at least one mutation was found in gyrA and/or parC in all four resistant strains (Table 1) . Except for S79T, similar amino acid changes in hot spot positions of ParC have been identified in other Gram-positive bacteria; these are S79R in E. faecalis and Enterococcus faecium, E83K in E. faecium and Staphylococcus aureus, and D78N and D83G in S. pneumoniae (1, 5, 7, 9) . Concerning GyrA, an identical mutation (S84L) has also been identified in S. aureus, E. faecium, and Streptococcus agalactiae (6, 9) . These findings suggest that topoisomerase IV seems to be the primary target of fluoroquinolones in Aerococcus spp., as previously described in other Gram-positive bacteria (4, 9) . Nucleotide sequence accession numbers. The QRDR sequences of the gyrA, gyrB, parC, and parE genes of A. urinae HM 384 (susceptible strain) have been submitted to GenBank under accession no. HM744700, HM744701, HM744702, and HM744703, respectively, as have those of A. sanguinicola HM 1273 (susceptible strain), under accession no. HM744704, HM744705, HM744706, and HM744707, respectively.
